TASSO, M. et al. Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy. Reumatismo, [S. l.], v. 74, n. 3, 2022. DOI: 10.4081/reumatismo.2022.1511. Disponível em: https://www.reumatismo.org/reuma/article/view/1511. Acesso em: 24 nov. 2024.